TWO SIGMA INVESTMENTS, LP - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 82 filers reported holding OVID THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,129,000
+41.3%
288,780
-16.5%
0.00%
+50.0%
Q4 2020$799,000
-56.5%
345,706
+7.9%
0.00%
-71.4%
Q3 2020$1,838,000
+1897.8%
320,265
+932.7%
0.01%
+600.0%
Q1 2020$92,000
-86.9%
31,012
-81.6%
0.00%
-50.0%
Q4 2019$700,000
+3584.2%
168,602
+1528.7%
0.00%
Q2 2019$19,000
-74.7%
10,352
-75.6%
0.00%
Q1 2019$75,000
-34.2%
42,360
-10.4%
0.00%
Q4 2018$114,00047,2630.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders